The mechanisms underlying the functional improvement after injection of multipotent mesenchymal stromal cells (MSCs) in infarcted hearts remain incompletely understood. The aim of this study was to investigate if soluble factors secreted by MSCs promote cardioprotection. For this purpose, conditioned medium (CM) was obtained after three passages from MSC cultures submitted to 72 h of conditioning in serum-free DMEM under normoxia (NCM) or hypoxia (HCM) conditions. CM was concentrated 25-fold before use (NCM-25X, concentrated normoxia conditioned medium; HCM-25X, concentrated hypoxia conditioned medium). The in vitro cardioprotection was evaluated in neonatal ventricular cardiomyocytes by quantifying apoptosis after 24 h of serum deprivation associated with hypoxia (1% O 2 ) in the absence or presence of NCM and HCM (nonconcentrated and 25-fold concentrated). The in vivo cardioprotection of HCM was tested in a model of myocardial infarction (MI) induced in Wistar male rats by permanent left coronary occlusion. Intramyocardial injection of HCM-25X (n = 14) or nonconditioned DMEM (n = 16) was performed 3 h after coronary occlusion and cardiac function was evaluated 19-21 days after medium injection. Cardiac function was evaluated by electro-and echocardiogram, left ventricular catheterization, and treadmill test. The in vitro results showed that HCM was able to decrease cardiomyocyte necrosis. The in vivo results showed that HCM-25X administered 3 h after AMI was able to promote a significant reduction (35%) in left ventricular end-diastolic pressure and improvement of cardiac contractility (15%) and relaxation (12%). These results suggest that soluble factors released in vitro by MSCs are able to promote cardioprotection in vitro and improve cardiac function in vivo.
INTRODUCTION
tempting to conclude that cell therapy exerts its dominant effects through differentiation. Based on this principle, cell therapy with MSCs after myocardial infarction Multipotent mesenchymal stromal cells (MSCs) are plastic-adherent cells with heterogeneous morphology (MI) was first proposed aiming to regenerate the heart by replacing lost tissue (21, 30, 45) . obtained from different tissues, including bone marrow (12, 15) . Several studies have shown that these cells are However, there is increasing evidence showing that differentiation of bone-marrow derived cells into host capable of differentiation, in vitro, into various cell types such as adipocytes, osteocytes, chrondocytes, and, tissue cells and/or even cell fusion (2,49) do not occur in vivo at a frequency high enough to explain functional in some instances, cardiomyocytes (17, 24, 39) . Given the large amount of in vitro data regarding the plasticity of improvement observed after cell therapy (5, 7, 16) . Furthermore survival of MSCs and engraftment after cell various bone marrow-derived cell populations, it is 1012 FIDELIS-DE-OLIVEIRA ET AL. injection seems to be minimal despite functional Gibco-Invitrogen, Carlsbad, CA, USA) and the cell suspension centrifuged in Ficoll gradient at 400 × g for 30 improvement, which suggests that beneficial indirect effects may manifest earlier and independent of engraft-min (Histopaque 1.083 g/ml, 1:1, Sigma-Aldrich, St. Louis, MO, USA). Mononuclear cells were collected ment (8, 38, 54, 59) . Thus, other mechanisms are likely to contribute to the benefits seen after therapy using MSCs, from histopaque medium interface. Cells were washed in buffered saline solution (BSS) three times, counted in such as the paracrine release of soluble factors by these cells (22, 23) . One of the studies aimed at directly evalu-a hemocytometer, and checked for viability using 0.4% trypan blue. Cells were then plated at a density of 1.2 × ating this hypothesis in infarcted hearts was conducted using MSCs overexpressing Akt1 (Akt-MSCs) (13) . 10 6 cells/cm 2 and maintained at 37°C in a 5% CO 2 incubator for 1 week, during which medium was changed at These authors showed that conditioned medium obtained from Akt-MSCs was able to promote cardioprotection in least twice, washing away all floating hematopoietic cells. Culture medium used was DMEM supplemented cardiomyocytes subject to hypoxia in vitro and improved cardiac function evaluated in a Langendorf preparation.
with 10% fetal bovine serum (Gibco-Invitrogen, Carlsbad, CA, USA), 2 mM L-glutamine (Sigma-Aldrich), An antiapoptotic paracrine effect has been suggested as a mechanism for the improvement of heart function and antibiotics (100 U/ml penicillin G and 100 µg/ml streptomycin, Gibco). At approximately 80-90% con-after cell therapy with MSCs in infarcted hearts (7, 13, 51) . It is known that after MI, necrosis is the pre-fluence, adherent cells were detached from the culture flasks with 0.25% trypsin-EDTA (Sigma-Aldrich) and vailing form of damage produced by coronary artery occlusion, but apoptotic cell death also contributes to the replated at a density of 1.2 × 10 4 cells/cm 2 . These cells were further propagated until passage 3 for collecting loss of myocytes in the ischemic heart (20) and the remote area of the infarct (6, 11, 42) . Although the rele-conditioned medium. These cells, purified by adherence to plastic culture flasks, were demonstrated to be posi-vance of cell death in the pathophysiology of MI has been reported by several studies in animal models tive for CD29 and CD90 surface markers and negative for CD34, CD45, and CD11b and, additionally, capable (20,29,37) and in humans (1, 28, 35, 42) , cytoprotective therapy and its clinical relevance are still limited of differentiating into osteoblasts and adipocytes (10). Together, these findings are in accordance to criteria for (18, 26, 46) . Studies focused on investigating antiapoptotic and antinecrotic effects of soluble factors released MSC definition established by International Society for Cellular Therapy (15) . from MSCs and their relevance for recovery of cardiac function after MI are still scarce (13, 44, 55) .
Collection of Conditioned Medium Therefore, the aim of the present study was, first, to After the third replating (1.2 × 10 4 cells/cm 2 ) had investigate if soluble factors released by MSCs in culreached approximately 70-80% confluence, the culture ture under normoxia and hypoxia conditions are able to was gently rinsed three times with BSS and the standard promote cardioprotection in vitro by antiapoptotic and/ medium was replaced by serum-free DMEM. Cells were or antinecrotic effect. In addition, we conducted experithen incubated under normoxia or hypoxia condition (O 2 ments in vivo using hypoxic MSC-conditioned medium 1% and CO 2 5%) at 37°C in a CO 2 /O 2 incubator (Therin animals infarcted by left anterior descendent coronary moforma model 3130). After 72 h of conditioning, conartery ligation.
ditioned medium (CM) obtained under normoxia (NCM) or hypoxia (HCM) condition was centrifuged and fil-MATERIALS AND METHODS tered through a 0.22-µm filtration device. After each Animals medium collection, the cells were detached by tripsin-All procedures were performed in accordance with EDTA 0.25% and counted in hematocytometer. Approx-US National Institutes of Health guidelines as attested imately 15 ml of CM was obtained by conditioning 10 6 to by the competent institutional board.
cells. In addition, cell viability was tested after both nor-Wistar rats (200-250 g) were housed at controlled moxia and hypoxia conditions. NCM and HCM were temperature (23°C) with daily exposure to a 12-h light/ concentrated 25-fold by ultrafiltration using a centridark cycle (lights on 08:00-20:00 h) and free access to prep device (YM-10 Millipore) equipped with a 10 both water and standard rat chow.
kDa cut-off membrane. Nonconditioned serum-free culture medium (DMEM) was submitted to the same proce-Multipotent Mesenchymal Stromal Cell Culture dure and used as control. The isolation and primary culture of MSCs was per-Cardiomyocyte Culture and Experimental Conditions formed as described by Caplan (9). Briefly, total rat bone marrow was harvested by flushing the tibias and
In vitro effect of CM was tested on ventricular myocytes isolated from the hearts of neonatal Wistar rats femurs with Dulbecco's modified Eagle medium (DMEM,
(1-2 days after birth). Neonatal cardiomyocytes were
In Vivo Study of Effect of Conditioned Medium obtained according to Suadicani et al. (47) . Briefly,
In vivo cardioprotective effect of CM was tested in a hearts from neonatal rats were removed, minced, and model of acute myocardial infarction (AMI) induced in serially digested by dissociative solution (NaCl 136.7 Wistar male rats weighing 200-250 g. mM; KCl 2.68 mM; Na 2 HPO 4 0.352 mM; NaHCO 3 11.9
Myocardial Infarction. MI was induced by left coro-mM; dextrose 11 mM) containing pancreatin (1.25mg/ nary artery ligation as previously described (34) . Briefly, ml; sigma) and bovine serum albumin (3 mg/ml; rats were anesthetized with halothane (Merck, Deutsch-Sigma). Each successive digestion lasted for 5 min at land) and a small thoracotomy was made on the left side 37°C with gentle stirring and the cells obtained were between the fifth and sixth ribs. After exposing the suspended in growth medium containing 10% fetal heart, the descending branches of the left coronary artery bovine serum (FBS) for inhibition of proteolytic were permanently occluded with a 5.0 silk suture, and enzymes. Elimination of non-muscle cells was achieved then the chest was closed. Sham-operated animals by preplating twice for 1 h each. After that, the cells underwent the same procedure but without the corowere counted and seeded in 24-well plates at a density nary ligation. of 1.5 × 10 5 cells/well and cultured in DMEM high glu-Experimental Protocol. The aim of these expericose containing 10% FBS at 37°C and 5% of CO 2 . ments was to investigate if soluble factors released in Experimental in vitro conditions were established 48-72 vitro by MSC under hypoxia would improve cardiac h after plating. Then cultures were washed with BSS function in AMI. For this purpose, 3 h after coronary and cardiomyocyte apoptosis was induced by serum occlusion, animals were reanesthetized and electrocardideprivation (S−) associated to hypoxia (H+) at 1% O 2 ography (ECG) and echocardiography (ECHO) were using a CO 2 /O 2 incubator for 24 h in the absence (cell performed to confirm infarction. Immediately after that, death induction; S−/H+) or presence of CM (NCM or rats were randomly selected and the chest was reopened HCM) at two different dilutions: nonconcentrated and for intramyocardial single injection of 100 µl of CM 25-fold concentrated. For the control normoxic condipreviously obtained under hypoxia and concentrated 25tion (control, S+/H−), we used DMEM with 10% FBS fold (HCM-25X; n = 14) or of nonconditioned serumand the culture was submitted to 24 h of 21% O 2 and free culture medium (DMEM, control; n = 16). Injection 5% CO 2 . Three independent experiments were made in was made at the border of MI. Cardiac function was triplicate for each experimental condition. evaluated 19-21 days later. Sham animals (SHAM; n = 9) were used as controls.
Cardiomyocyte Apoptosis/Necrosis Assay
Apoptosis and necrosis were identified by means of Functional Analyses double fluorescence staining with Annexin V-fluores-Electrocardiogram. The animals were anesthetized cein isothiocyanate (FITC)/propidium iodide (PI) apowith ketamine and xylazine (50 and 5 mg/kg, respecptosis detection kit (Sigma). Briefly, after 24 h under tively, IP) and placed in the supine position. Electrodes experimental conditions, cardiomyocytes from each well were connected to surgical needles and inserted subcutawere separately collected after rinsing with Ca 2+ and neously in order to record the classical six limb leads Mg 2+ -free saline solution three times. The remaining (L1, L2, L3, aVR, aVL, and aVF) as previously attached cardiomyocytes were removed by adding 500 described (41). âQRS > 90°and presence of Q wave in µl/well of trypsin-EDTA (0.25%) without rinsing for 3 L1 were used as evidence of infarction, as previously min. After that, trypsin was inactivated by adding 2 ml shown (27) . of DMEM supplemented with 10% FBS and the cells were centrifuged at 250 × g for 5 min. For quantification Echocardiogram. Echocardiographic examination was performed blinded by the same echocardiographist, fol-of cardiomyocyte death, the pellet was resuspended in 500 µl of binding buffer (HEPES 10 mM; NaCl 140 lowing the American Society of Echocardiography (ASE) recommendations. We used an echocardiographic color mM; CaCl 2 2.5 mM; dextrose 11 mM) and incubated in the dark for 10 min with 5 µl of Annexin V-FITC and system (Megas/Esaote) equipped with a 10-MHz electronic-phased-array transducer. Short-axis two-dimen-10 µl of PI at room temperature. Dual color analysis was performed using a FACScalibur flow cytometer (Becton sional views of the left ventricle (LV) were taken at the level of the papillary muscles. In order to estimate LV Dickinson) by counting 20,000 cells (FL1-H filter for Annexin V-FITC and FL3-H filter for PI). This combi-global function, we calculated LV diastolic and systolic area (LVDA, LVSA, respectively) to determine frac-nation detects cells in apoptosis (Annexin V positive, PI negative), necrosis (Annexin V positive, PI positive), tional shortening area: FSA (%) = [(LVDA − LVSA)/ LVDA] × 100. and viable cells (Annexin V negative, PI negative) (52) .
Treadmill Test. Nineteen days after MI animals were (baseline and after injection) were evaluated by two-way ANOVA followed by Bonferroni post hoc test. The weighted and had their cardiac function analyzed under physiological stress (exercise). The test was performed ECG QRSi at 21 days, exercise time, and left ventricular parameters between DMEM and HCM-25X were ana-according to an already established protocol (53). We evaluated the maximal time of endurance running of the lyzed by nonpaired t-test. Values were considered significant when p < 0.05. animals. In brief, after an adaptation period of 3 days running at 17 cm/s for 5 min, the animals started to run RESULTS in a treadmill with a constant slope of 10°and velocity
In Vitro Effect of Conditioned Medium Obtained of 17 cm/s. Each 2 min, the velocity was increased by Under Normoxia 2 cm/s until exhaustion. Stainless steel grids provided an electrical shock to keep the animals running. Exhaus-
The putative cytoprotective effect of CM was tested tion was determined whenever the animal stayed on the first in vitro on cardiomyocytes submitted to serum depsteel grids for more than 15 s despite the shocks.
rivation associated to hypoxia (S−/H+). Nonconcentrated and 25-fold concentrated NCM and HCM were Left Ventricular Pressure Measurements in Unanesused. As expected (Fig. 1A) , apoptosis (Annexin-V + /PI − ) thetized Rats. Twenty-one days after MI, animals were anesthetized with ketamine/xylazine and the right carotid artery was cannulated with a PE10 catheter. One extremity of the catheter was inserted into the left ventricle and the opposite end was tunneled back and exposed between the scapulae. With the animal free to walk about in its cage 24 h after this procedure, the catheter was connected to a pressure transducer (MLT0380/D, ADInstruments) coupled to a Power Lab400 acquisition system (ADInstruments) and LV pressure was measured in awake nonanesthetized animals according to protocol established per our group in infarcted rats (53). After an adaptation period of 30 min, LV pressure acquisition started. The left ventricular parameters evaluated were: left ventricular end diastolic pressure (LVEDP), left ventricular end systolic pressure (LVESP), left ventricular developed pressure [(LVDP) = LVESP − LVEDP], cardiac index of left ventricular contractility (dPdT+: rate of pressure rise), and index of left ventricular relaxation (dPdT−: rate of pressure decay). All values were measured using Chart 4 software (PowerLab, ADInstruments).
Histological Procedures
After all cardiac function analysis, the animals were sacrificed and had their hearts excised for histological analysis. After arrest in diastole by KCl (30 mM) perfusion, the hearts were fixed by immersion in 4% paraformaldehyde in phosphate buffer. Ventricles were sectioned in four slices from apex to base (A, B, C, and D, respectively). Infarct size determination was performed by computer-assisted planimetry (ImageJ ver- test. For the in vivo study, ECHO and AQRS parameters was higher under hypoxia (S−/H+: 16 ± 4%) than normoxia (S+/H−: 5 ± 1%) condition. Nonconcentrated NCM was not able to prevent cardiomyocyte apoptosis (NCM: 18 ± 6%) even when 25-fold concentrated. Although with the concentrated medium there was tendency to reduce apoptosis, this did not reach statistical significance (NCM-25X: 10 ± 5%).
The percentage of necrosis (Annexin-V + /PI + ) ( Fig.  1B) was again higher at hypoxia (9 ± 2%) than normoxia (4 ± 1%). Under this condition, neither NCM nor NCM-25X was able to reduce percentage of cardiomyocyte necrosis (NCM: 5 ± 1%; NCM-25X: 7 ± 3%).
In Vitro Effect of Conditioned Medium Obtained Under Hypoxia
We postulated that CM obtained under hypoxia (HCM) would better mimic soluble factors release by MSC injected at the border zone in vivo after a myocardial infarction. After 24 h of hypoxia ( Fig. 2A) , we observed that independent of the HCM concentration used, cardiomyocyte apoptosis had a tendency to decrease but did not reach statistical significance when compared to hypoxia and serum deprivation (HCM: 12 ± 4%; HCM-25X: 13 ± 6% vs. 17 ± 4% under S−/H+). However, necrosis (Fig. 2B ) was significantly attenuated by HCM 25-fold concentrated (HCM-25X: 4 ± 1% vs. 9 ± 2% under S−/H+; p < 0.05). 
tion. Intramyocardial injection of DMEM or HCM-25X
was not able to reverse rightward deviation, but 21 days after MI QRSi was approximately 28% lower in Exercise Test. All infarcted groups presented lower DMEM-injected animals (0.92 ± 0.07 mV) than in exercise capacity, shown as total exercise time ( Fig. 4) , HCM-25X (1.18 ± 0.05 mV, p < 0.01), which suggests compared to sham animal (Sham: 22.5 ± 1.1 min). Exera larger mass of depolarizing myocytes and/or better cise capacity was unchanged after medium injection and electrical conductivity in the infarcted hearts that no difference was observed between infarcted groups received HCM-25X.
(DMEM: 14.47 ± 0.7 min; HCM-25X: 14.92 ± 1.3 min). Therefore, intramyocardial injection of HCM was not ECHO. Three hours after MI, all infarcted groups able to improve cardiac function under physiological presented similar decreased FSA values (DMEM: 40 ± stress induced by exercise. 2%; HCM-25X: 35 ± 3%; p > 0.05) when compared to Sham (65 ± 4%) ( Fig. 3) . At 21 days, FSA was maintained Left Ventricular Pressure Measurements in Unanesthetized Rats. The left ventricular pressure (LVP) in Sham animals while in the DMEM control group additional reduction of approximately 22% was observed (31 ± parameters in unanesthetized rats measured 21 days after medium injection are shown in Figure 5 . All infarcted 2% vs. 40 ± 2% at 3 h; p < 0.01). HCM-25X injection diminished this reduction in FSA (31 ± 3% vs. 35 ± 3% groups showed increases in LVEDP and reductions in LVSP, LVDP, and contractility (DPDT+) and relaxation at 3 h; p > 0.05). However, FSA at 21 days in HCM-25X was not different from the DMEM group.
( Infarct Size. Figure 6 summarizes the results of infarct size. Left coronary artery ligation induced large infarcts (40% in average). Intramyocardial injection of HCM-25X was not able to reduce infarct size when administered 3 h released by MSCs were responsible for attenuating myo-DMEM: 20 ± 2 mmHg, p < 0.05). In addition, HCMcyte loss and thus promoting improved function. This 25X injection increased cardiac contractility (Fig. 5C) same group later showed that injection of MSC-Akt conby approximately 15% (HCM-25X: 6169 ± 347 mmHg/ ditioned medium only was sufficient to promote similar improvements in cardiac function and that cell incorporation in native tissue was not necessary (13) .
In the present study, we opted to obtain CM from MSCs not genetically modified but exposed to conditions similar to those encountered in the postinfarct myocardium (i.e., under hypoxic conditions). It is known that hypoxia increases the secretion of growth and angiogenic factors, and cytokines such as fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), angiopoietin 1 (Ang-1), platelet-derived growth factor (PDGF), interleukin-1 (IL-1) and IL-6 by MSCs in culture (23) . The conditioning time of 72 h was chosen based on the literature (22, 23) and on experiments using CM on chicken embryo sympathetic neurons, a throphic sensor model (40) , where CM obtained submitted to hypoxia for 24 h. Preliminary results using of wall stress in infarcted hearts (19) , preventing additional cell death in remote areas to infarction along ethidium bromide staining in permeabilized cardiomyocytes followed by flow cytometry quantification of cell time (32) . It could be argued that the increased heart rate hypodiploid content showed that CM obtained under normoxia reduced cardiomyocyte apoptosis induced by observed in the HCM group was responsible for the lower LVEDP and for better cardiac contractility and serum deprivation for 24 h (data not shown). In subsequent experiments, we opted to use Annexin V/PI stain-relaxation. However, the relationship between heart rate and contractility seems to be complex in rat heart, differ-ing and flow cytometric quantification aiming to discriminate apoptosis from necrosis. In vitro results ing from other mammals (31, 48, 50) . In fact, Nalivaiko et al. (31), using a rat heart-brain stem preparation, showed that CM obtained either under normoxia or hypoxia conditions was not able to significantly reduce showed that the contractility falls if the pacing rate rises within the physiological range (200-500 beats min −1 ), the percentage of cardiomyocytes in apoptosis induced by hypoxia and serum deprivation. On the other hand, but it also tends to fall during substantial drops of heart rate. This force-frequency relationship seems to be HCM-25X diminished the percentage of cardiomyocytes in necrosis. Spontaneously beating cardiomyocytes were related to Ca 2+ dynamics. These same authors showed that LVEDP increases with augmentation in heart rate visualized under experimental conditions with NCM and HCM, in contrast to that observed with control DMEM due to reduction in relaxation time. Together, these observations exclude the fact that variations in heart rate in which spontaneous contractions were always absent. These results suggest that soluble factors released by in our study, which was kept within rat physiological range, are responsible for alteration on LV parameters MSCs under hypoxia protect cardiomyocyte from necrosis.
Based on our in vitro results and considering that in the HCM-25X group. Our in vivo results are at odds with Gnecchi et al. necrosis is the main cell death mechanism after MI, we aimed to investigate in vivo if a single intramyocardial (13) , who showed no improvement in cardiac function with CM obtained under hypoxia from nonmodified injection of CM obtained under hypoxia would be able to improve cardiac function when injected 3 h after MI.
MSCs. These authors only demonstrated improvement in cardiac function when CM was obtained from MSCs Hypoxic medium for in vivo experiments was chosen, aiming to better mimic the ischemic microenvironment genetically modified to overexpress Akt. Here, we demonstrated that although modest, CM obtained under and to test the hypothesis of a paracrine mechanism. It is known that hypoxia can induce upregulation of various hypoxia from nonmodified MSCs can prevent additional reduction in cardiac function with time, improve cardiac factors related to angiogenesis and survival, and even lead to expression of cytoprotective factors not normally contractility and relaxation, and decrease LVEDP. Conditioning time of 12 h and/or the window for myocardial expressed under normoxia (13, 23) .
We showed that a single intramyocardial injection of injection (30 min after MI) besides different methodological approaches for functional analysis chosen by HCM-25X was not able to improve cardiac performance but prevented additional reduction in cardiac function these authors may explain the difference in results. In addition, functional improvement using non-genetically evaluated by ECHO by means of FSA. In addition, ECG studies showed that although QRS right axis deviation modified MSCs has been reported in several studies in the literature, suggesting that factors secreted by these was not prevented by CM injection, QRS index at 21 days was 28% higher in the HCM-25X than in the cells promote cardioprotection (3,7, 16, 45) . In relation to infarct magnitude, the results of our study DMEM group. In awake nonanesthetized rats, a single intramyocardial injection of HCM-25X promotes signif-showed that CM obtained under hypoxia was not able to alter infarct size. However, functional improvement has icant reduction (ϳ35%) in LVEDP and improvement in cardiac contractility (ϳ15%) and relaxation (ϳ12%) been recorded after cell therapy with MSCs even without changes in infarct size (7, 16) . In addition, we cannot rule compared to control DMEM injection. Improvement in cardiac contractility and relaxation per se may be out the putative hypertrophic effect of CM on the remaining myocardium. Indeed, Xu et al. (56) demonstrated that responsible for decreased LVEDP observed in the HCM-25X group. In addition, we can speculate that this MSCs promote cardiomyocyte hypertrophy through hypoxia-induced paracrine mechanisms. reduction in LVEDP and improvement in relaxation may also be related to an antifibrotic effect of CM (5,58) in Since we did not measure capillary density, one cannot rule out the possibility of functional improvement areas remote to infarction or even remodeling effect on scar tissue (57), increasing cardiac compliance and pro-also being due to a paracrine angiogenic effect, since many of the MSCs secreted factors are known to partici-moting improvement in diastolic function (33, 44) . It is known that reduction in LVEDP promotes attenuation pate in the angiogenesis process. However, functional improvement after therapy with MSCs described by REFERENCES some authors seems to occur more rapidly than the time 1. Abbate, A.; Biondi-Zoccai, G. G. L.; Baldi, A. Pathophysrequired for angiogenesis (13, 25) . 
